Search Results

Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]

Authors: Wang, Daoyuan; He, Jianxing

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 1-1(1)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer

Authors: Konopa, Krzysztof; Jassem, Jacek

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 2-11(10)

Publisher: Bentham Science Publishers

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)

Authors: Giovannetti, Elisa; Honeywell, Richard; Hanauske, Axel R.; Tekle, Christina; Kuenen, Bart; Sigmond, Jennifer; Giaccone, Giuseppe; Peters, Godefridus J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 12-28(17)

Publisher: Bentham Science Publishers

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer

Authors: Chen, Manyin; Shao, Wenlong; He, Jianxing; Wang, Daoyuan

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 29-36(8)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action

Authors: Joerger, M.; Omlin, A.; Cerny, T.; Fruh, M.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 37-47(11)

Publisher: Bentham Science Publishers

Predictive Markers for Haematological Toxicity of Pemetrexed

Authors: Kao, S. C.H.; Phan, V. H.; Clarke, S. J.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 48-57(10)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer

Author: Tucker, Steven

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 58-60(3)

Publisher: Bentham Science Publishers

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer

Authors: Ngeow, Joanne; Toh, Chee-Keong

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 61-66(6)

Publisher: Bentham Science Publishers

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Authors: Wagner, Timothy D.; Yang, Gary Y.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 67-73(7)

Publisher: Bentham Science Publishers

The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features

Authors: Duruisseaux, Michael; Cadranel, Jacques; Perol, Maurice; Arpin, Dominique

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 74-77(4)

Publisher: Bentham Science Publishers

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

Author: Vincent, Mark

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 78-84(7)

Publisher: Bentham Science Publishers

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer

Authors: Li, Tianhong; Lara Jr., Primo N.; Mack, Philip C.; Perez-Soler, Roman; Gandara, David R.

Source: Current Drug Targets, Volume 11, Number 1, January 2010 , pp. 85-94(10)

Publisher: Bentham Science Publishers

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

Authors: Ozasa, Hiroaki; Oguri, Tetsuya; Uemura, Takehiro; Miyazaki, Mikinori; Maeno, Ken; Sato, Shigeki; Ueda, Ryuzo

Source: Cancer Science, Volume 101, Number 1, January 2010 , pp. 161-166(6)

Publisher: Blackwell Publishing

Erlotinib: A Pharmacoeconomic Review of its Use in Advanced Non-Small Cell Lung Cancer

Author: Lyseng-Williamson, Katherine A.

Source: PharmacoEconomics, Volume 28, Number 1, 1 January 2010 , pp. 75-92(18)

Publisher: Adis International

Updated treatment guidelines for stage IV NSCLC

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 2-2(1)

Publisher: Adis International

Cisplatin + pemetrexed as first-line therapy for advanced NSCLC

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 593, 2009-12-12 , pp. 5-5(1)

Publisher: Adis International

Pemetrexed: Acute myocardial infarction: case report

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 37-37(1)

Publisher: Adis International

Emerging role of pemetrexed in ovarian cancer

Authors: Tomao, Federica; Panici, Pierluigi Benedetti; Frati, Luigi; Tomao, Silverio

Source: Expert Review of Anticancer Therapy, Volume 9, Number 12, December 2009 , pp. 1727-1735(9)

Publisher: Expert Reviews

The cost utility of pemetrexed as first-line therapy for advanced non-small cell lung cancer appears to be hindered by poor basal QOL

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 8-8(1)

Publisher: Adis International

Phase Ib safety and pharmacokinetic evaluation of daily and twice daily oral enzastaurin in combination with pemetrexed in advanced/metastatic cancer

Authors: Hanauske, A.-R.; Lahn, M.; Musib, L. C.; Weigang-Khler, K.; Yilmaz, E.; Graefe, T.; Kuenen, B.; Thornton, D.; McNealy, P.; Giaccone, G.

Source: Annals of Oncology, Volume 20, Number 9, 24 September 2009 , pp. 1565-1575(11)

Publisher: Oxford University Press